News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
Sleep-Aligned Fasting May Support Overnight Heart Health
July 9, 2026 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Researchers found that aligning fasting with the body’s natural sleep cycle before bedtime may support cardiovascular and metabolic health.
Read Article
AMP® BGTC Announces FDA Clearance of Investigational New Drug Application for Gene Therapy Targeting Multiple Sulfatase Deficiency
July 6, 2026 - Grantee/Partner News
- Bespoke Gene Therapy Consortium (BGTC)
The FDA cleared the Investigational New Drug (IND) application for a gene therapy designed to treat children with multiple sulfatase deficiency (MSD), an ultra-rare disease.
Read ArticleNIH Research Clears Way for Study of Experimental Treatment for Opioid Use Disorder
June 1, 2026 - Media Coverage
- Helping to End Addiction Long-term® Initiative (HEAL)
Faster Chemical Reactions Made Possible by Tiny Droplets
June 1, 2026 - Grantee/Partner News
- ASPIRE
People With Chronic Back Pain May Be More Sensitive to Unpleasant Sounds
May 26, 2026 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Study finds people with chronic back pain may be more sensitive to unpleasant sounds, revealing sensory amplification that may be treatable.
Brain Regions React to Processed Diets in Unique Ways
May 21, 2026 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Researchers found that older rats that ate low-fiber, highly processed diets experienced brain inflammation and memory problems.
FDA Clears IND for Gene Therapy Candidate to Treat Rare Metabolic Disorder
May 21, 2026 - NCATS News
- Our Impact on Clinical Trials
- Our Impact on Drug Discovery and Development
- Our Impact on Rare Diseases
MMA-101, an NIH-supported AAV gene therapy for a rare metabolic disorder, has received FDA clearance to begin clinical testing.
NIH awards $50 million to UMass Center for Clinical and Translational Science
May 20, 2026 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program